Experience

Experience

Incyte Corporation et al. v. Sun Pharmaceutical Industries Limited et al.

Incyte Corporation et al.

Sun Pharmaceutical Industries Limited et al.

Successfully represented Incyte in patent litigation, including preliminary injunction proceedings related to Sun Pharmaceuticals’ deuterated Janus kinase (JAK) inhibitor, LEQSELVI™. Case settled favorably for our client.

Incyte Corporation et al. v. Sun Pharmaceutical Industries Limited et al., 2:24-cv-06944, D.N.J., Judge Padin

Related Professionals

Mark J. Feldstein, Ph.D.: Partner; Washington, DC; +1 202 408 4092; Email

Danielle A. Duszczyszyn, Ph.D.: Partner; Washington, DC; +1 202 408 4142; Email

J. Derek McCorquindale: Partner; Reston, VA; +1 571 203 2768; Email

Daniel F. Roland: Partner; Washington, DC; +1 202 408 4318; Email

M. David Weingarten, Ph.D.: Partner; Atlanta, GA; +1 404 653 6457; Email

John M. Williamson: Partner; Washington, DC; +1 202 408 4282; Email

Jason L. Romrell: Partner; Washington, DC; +1 202 408 4349; Email

Megan L. Meyers: Associate; Atlanta, GA; +1 404 653 6565; Email

Emma N. Ng: Associate; Washington, DC; +1 202 408 4149; Email

Shannon M. Patrick: Associate; Atlanta, GA; +1 404 653 6558; Email

Related Practices

Global IP Enforcement, Litigation, and Trials

Patent Litigation and Trials

Related Industries